Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
68.79
+2.31 (3.47%)
At close: Sep 21, 2026, 4:00 PM EDT
68.00
-0.79 (-1.15%)
After-hours: Sep 21, 2026, 6:27 PM EDT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $9.72 billion as of September 21, 2026. Its market cap has increased by 129.00% in one year.
Market Cap
9.72B
Enterprise Value
9.50B
1-Year Change
129.00%
Ranking
Category
Stock Price
$68.79
ChartMarket Cap Chart
Since January 15, 2004, Arrowhead Pharmaceuticals's market cap has increased from $300.00K to $9.72B, an increase of 3,238,864.93%. That is a compound annual growth rate of 58.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 9.72B | 7.77% |
| Dec 31, 2025 | 9.02B | 285.42% |
| Dec 31, 2024 | 2.34B | -28.84% |
| Dec 29, 2023 | 3.29B | -23.54% |
| Dec 30, 2022 | 4.30B | -37.84% |
| Dec 31, 2021 | 6.92B | -11.95% |
| Dec 31, 2020 | 7.86B | 29.67% |
| Dec 31, 2019 | 6.06B | 451.13% |
| Dec 31, 2018 | 1.10B | 299.42% |
| Dec 29, 2017 | 275.20M | 154.58% |
| Dec 30, 2016 | 108.10M | -70.48% |
| Dec 31, 2015 | 366.20M | -9.27% |
| Dec 31, 2014 | 403.60M | -3.88% |
| Dec 31, 2013 | 419.90M | 1,153.43% |
| Dec 31, 2012 | 33.50M | -24.04% |
| Dec 30, 2011 | 44.10M | -31.42% |
| Dec 31, 2010 | 64.30M | 93.09% |
| Dec 31, 2009 | 33.30M | -15.70% |
| Dec 31, 2008 | 39.50M | -72.93% |
| Dec 31, 2007 | 145.90M | -2.60% |
| Dec 29, 2006 | 149.80M | 25.99% |
| Dec 30, 2005 | 118.90M | 101.87% |
| Dec 31, 2004 | 58.90M | 19,533.33% |
| Jan 15, 2004 | 300.00K | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 10.88B |
| Twist Bioscience | 10.47B |
| Krystal Biotech | 9.97B |
| Kymera Therapeutics | 9.79B |
| Cytokinetics | 9.56B |
| Protagonist Therapeutics | 9.25B |
| ABIVAX Société Anonyme | 9.10B |
| ImmunityBio | 8.99B |